Suppr超能文献

菟丝子商品药材品种考证、资源调查与鉴定

[Varieties textual research, resource investigation and identification of commercial drugs on Cuscutae Semen].

作者信息

Wu Zhi-Gui, Fu Xiao-Mei, Wu Shu-Yao, Li Yang, Xie Bin, Chen Rui-Lin, Fan Cui-Sheng

机构信息

School of Pharmacy, Jiangxi University of Traditional Chinese Medicine, Nanchang 330004, China.

Fan Cuisheng Studio of Famous Traditional Chinese Medicine, Jiangxi University of Traditional Chinese Medicine, Nanchang 330006, China.

出版信息

Zhongguo Zhong Yao Za Zhi. 2017 Oct;42(19):3831-3835. doi: 10.19540/j.cnki.cjcmm.2017.0150.

Abstract

Through the textual research, resource investigation, literature reviews (including Flora of China, municipal Flora, pharmacopoeia of China and municipal drug standards) and identification of commercial drugs on Cuscutae Semen, it was found the species described in the herbal textual was Cuscuta chinensis, with good quality from Shandong and Henan Province. The identification of commodities showed the majority drugs were from C. australis, varied from the ancient herbal textuals .Mordern literature reviews indicate that it was necessary to strengthen the research on Cuscutae Semen from C. australis, C. chinensis and C. japonica because of their differences in resources, macroscopical and microscopical characters, while wrong descriptions in some literatures. It was suggested that the two species (C. australis and C. chinensis) should be separated in pharmacopoeia of China. The study provides scientific basis for the development and utilization of Cuscutae Semen.

摘要

通过对菟丝子的考证、资源调查、文献查阅(包括《中国植物志》《地方植物志》《中国药典》及地方药品标准)以及市售药材鉴定,发现本草记载的品种为中国菟丝子,山东和河南产的质量较好。商品鉴定表明,多数药材来自南方菟丝子,与古代本草记载不同。现代文献综述指出,由于南方菟丝子、中国菟丝子和日本菟丝子在资源、宏观和微观特征上存在差异,而一些文献中存在错误描述,因此有必要加强对这三种菟丝子的研究。建议在中国药典中将南方菟丝子和中国菟丝子分为两个品种。该研究为菟丝子的开发利用提供了科学依据。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验